16.1C
Delhi
Saturday, January 16, 2021

Over 60K sign up for Russian Covid vax, 700 injected

- Advertisement -

1st batch of Russian vaccine produced for civilian circulationMoscow, Sep 21 (IANS) More than 60,000 people have applied to volunteer for the coronavirus vaccine trials in Moscow and over 700 people have been injected with the coronavirus vaccine, the media reported.

Sputnik V, an adenovirus vector-based vaccine, was developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology, along with the Russian Direct Investment Fund and registered on August 11.

“Over 60,000 people have signed up as volunteers, several thousand people have passed the required medical tests to be registered as potential candidates for carrying out the tests,” Mayor Sergei Sobyanin was quoted as saying in reports on Sunday.

READ ALSO:  India's overwhelming influence forces China, Pakistan backing for UNSC seat

According to Russian Tass news agency, more than 700 people have been injected with the coronavirus vaccine.

“All of them are feeling good,” Sobyanin said.

The vaccine was developed on a platform that had been used for a number of other vaccines.

On August 15, the Russian Health Ministry announced the launch of the vaccine production.

The Russian Direct Investment Fund (RDIF) and Dr Reddy’s Laboratories Limited, a global pharmaceutical company headquartered in India, have also agreed to cooperate on clinical trials and distribution of Sputnik V Covid-19 vaccine in India.

“On regulatory approval in India, RDIF shall supply to Dr Reddy’s 100 million doses of the vaccine. The Sputnik V vaccine, which is based on well-studied human adenoviral vector platform with proven safety, is undergoing clinical trials for the coronavirus pandemic,” said a statement from the fund.

READ ALSO:  New global test will give Covid test results ‘in minutes’

The Russian Direct Investment Fund said that the deliveries could potentially begin in late 2020 subject to completion of successful trials and registration of the vaccine by regulatory authorities in India.

Earlier this month, a study published in the peer-reviewed journal The Lancet said a Russian Covid-19 vaccine has shown no serious side effects and elicited an immune response in early human trials.

READ ALSO:  Nearly half of global workforce at risk of losing livelihoods: ILO

Source: IANS

India Updates
India Updates is an independent news & Information website. Follow us for regular updates on News and Information.

Follow Us On

Related News

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Trending Topics In India

Covid 19 India Updates

Trending News In India

Trending Showbiz

Trending Sports

Latest Trending News In India

Javadekar pitches for private participation in 52nd IFFI edition

Panaji, Jan 16 (IANS) Union Minister for Information and Broadcasting Prakash Javadekar on Saturday pitched for private participation in the next edition of the...

RBI remains ‘steadfast’ to take necessary steps to support economy: Guv

New Delhi, Jan 16 (IANS) Reserve Bank Governor Shaktikanta Das on Saturday said that the central bank remains committed to take any further necessary...

RML hospital docs apprehensive about Covaxin, want Covishield

New Delhi, Jan 16 (IANS) Resident doctors at Delhi's Ram Manohar Lohia (RML) Hospital on Saturday expressed reservations over taking Bharat Biotech's 'Covaxin' due...

Vaccines safe, show faith in your own products: VK Paul

New Delhi, Jan 16 (IANS) Allaying the fears associated with the Covid-19 vaccination drive, V.K. Paul, Member (Health), NITI Aayog, emphasised on Saturday that...